Treatment of Adults with Autism Spectrum Disorder (ASD)

Behavioral and Educational Interventions

The American Academy of Child and Adolescent Psychiatry recommends structured behavioral interventions as first-line treatment for adults with ASD, focusing on specific target behaviors and functional skills 1
Applied Behavioral Analysis (ABA) techniques have demonstrated efficacy for addressing specific behavioral problems in ASD, including symptoms related to motivation and engagement 1
Structured educational programs with explicit teaching methods should be tailored to the individual's cognitive profile and communication needs, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 2
Cognitive behavioral therapy has shown efficacy for anxiety and anger management in higher functioning individuals with ASD, with a strength of evidence supported by the Journal of the American Academy of Child and Adolescent Psychiatry 2

The Journal of the American Academy of Child and Adolescent Psychiatry recommends explicit teaching of social reciprocity and pragmatic language skills for adults with ASD who have fluent speech but impaired pragmatic language skills 2
Alternative communication modalities, such as Picture Exchange Communication System and voice output communication aids, should be implemented for individuals who have limited verbal communication 1
Speech and language therapy is essential for individuals with significant language and communication challenges that may affect social functioning and quality of life 1

The American Academy of Child and Adolescent Psychiatry recommends that pharmacotherapy should target specific symptoms or comorbid conditions rather than the core features of autism, as there are currently no medications that effectively treat the core social communication deficits of ASD 3
For irritability and aggression, Risperidone (0.5-3.5 mg/day) or Aripiprazole (5-15 mg/day) are FDA-approved and recommended as first-line treatments, with a strength of evidence supported by Praxis Medical Insights 3
Methylphenidate has shown efficacy for hyperactivity and inattention in individuals with ASD, with a starting dose of 0.3-0.6 mg/kg/dose, 2-3 times daily 3

Evaluate for comorbid conditions that may require specific treatment, including depression (20% vs 7% in non-ASD population), anxiety (11% vs 5%), sleep difficulties (13% vs 5%), and epilepsy, as recommended by Praxis Medical Insights 1
Regular assessment of treatment response using standardized rating scales is recommended for monitoring effectiveness of interventions, with a strength of evidence supported by Praxis Medical Insights 3

Family involvement is important to ensure generalization of skills across different settings, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 2

Combining medication with behavioral interventions is more efficacious than medication alone for decreasing serious behavioral disturbance, with a strength of evidence supported by Praxis Medical Insights 3